BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11347049)

  • 1. [Abnormal lipid metabolism in chronic renal failure].
    Okubo M; Naito M; Nakamura M
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():156-61. PubMed ID: 11347049
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipid metabolism disorders in patients with chronic renal failure].
    Zdrojewski Z
    Pol Tyg Lek; 1982 May; 37(13):391-3. PubMed ID: 7134045
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of lipolytic enzymes in the physiopathology of plasma lipoprotein metabolism].
    Szeszko A; Lutz W
    Pol Tyg Lek; 1982 Jul; 37(22):657-61. PubMed ID: 6757901
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipid alterations in patients with chronic renal disease.
    Cramp DG
    Crit Rev Clin Lab Sci; 1982; 17(1):77-101. PubMed ID: 6749432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid abnormalities in progressive renal insufficiency.
    Attman PO; Samuelsson O; Alaupovic P
    Contrib Nephrol; 1997; 120():1-10. PubMed ID: 9257042
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperlipidemia of chronic renal failure.
    Kaysen GA
    Blood Purif; 1994; 12(1):60-7. PubMed ID: 7986478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R; Borggreve SE; Dullaart RP
    Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipoprotein alterations in thyroid dysfunction. Roles of lipoprotein lipase, hepatic lipase and LCAT.
    Valdemarsson S
    Acta Endocrinol Suppl (Copenh); 1983; 255():1-52. PubMed ID: 6575562
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolism of magnesium and lipid disturbances in chronic renal failure].
    Fijałkowska-Morawska J; Chrzanowski W
    Pol Arch Med Wewn; 1997 Oct; 98(10):327-31. PubMed ID: 9557087
    [No Abstract]   [Full Text] [Related]  

  • 11. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.
    Vaziri ND
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F262-72. PubMed ID: 16403839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in factors that alter lipid metabolism in chronic renal failure.
    Drüeke T; Lacour B; Roullet JB; Funck-Brentano JL
    Kidney Int Suppl; 1983 Dec; 16():S134-8. PubMed ID: 6588243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lecithin: cholesterol acyltransferase and the regulation of endogenous cholesterol transport.
    Dobiásová M
    Adv Lipid Res; 1983; 20():107-94. PubMed ID: 6422708
    [No Abstract]   [Full Text] [Related]  

  • 14. Statins as effectors of key activities involved in apoE-dependent VLDL metabolism: review and hypothesis.
    Dergunov AD; Visvikis-Siest S; Siest G
    Vascul Pharmacol; 2008; 48(2-3):70-5. PubMed ID: 18221919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High-density cholesterol lipoprotein: metabolism and role in atherosclerosis].
    Bruckert E; Giral P; Dairou F; De Gennes JL
    Presse Med; 1988 May; 17(17):862-6. PubMed ID: 2968582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid abnormalities in uremia, dialysis, and transplantation.
    Chan MK; Varghese Z; Moorhead JF
    Kidney Int; 1981 May; 19(5):625-37. PubMed ID: 7026870
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lipid metabolism disorders in kidney failure].
    Romics L; Makó J
    Orv Hetil; 1978 Dec; 119(50):3055-8. PubMed ID: 215956
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relationship between the activity of lecithin cholesterol acyltransferase, hyperlipoproteinemia type and the indicators of the system of hemostasis in chronic ischemic heart disease].
    Furkalo NK; Bol'shakova RM; Solovtsova KM; Mkhitarian LS; Progonnaia VV
    Vrach Delo; 1978 Dec; (12):33-8. PubMed ID: 217177
    [No Abstract]   [Full Text] [Related]  

  • 19. [Primary and secondary changes in high-density lipoproteins].
    Rubiés-Prat J
    Rev Clin Esp; 1987 Oct; 181(6):327-31. PubMed ID: 3432700
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasma lipoproteins: biochemistry and molecular pathology].
    Yamamoto A; Tajima S; Ikeda Y
    Seikagaku; 1990 Feb; 62(2):89-112. PubMed ID: 2158519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.